Health insurer stocks are experiencing a sharp decline in premarket trading Tuesday following a proposal from the Trump administration regarding Medicare Advantage plan payments.

The proposal outlines a smaller-than-anticipated increase for next year's Medicare Advantage plans, disappointing investors and triggering a sell-off. UnitedHealth, a major player in the health insurance sector, saw its shares drop by a significant 8%.

Medicare Advantage plans offer an alternative to traditional Medicare, allowing beneficiaries to receive their healthcare services through private insurance companies that contract with Medicare. These plans often include additional benefits and may have lower out-of-pocket costs for some beneficiaries. The annual payment rates set by the Centers for Medicare & Medicaid Services (CMS) significantly impact the profitability of these plans for insurers.

The proposed reduction in payment increases is likely due to efforts to control healthcare costs and ensure the long-term financial stability of Medicare. While the details of the proposal are still being reviewed, the initial reaction from the market suggests concerns about the potential impact on insurer revenue and investment in Medicare Advantage programs.

The Trump administration’s proposal is subject to further review and potential revisions before it takes effect. Investors are closely monitoring the situation for further developments and their potential implications for the health insurance industry.